Corrigendum: Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic

Yim, Rebecca M; Singh, Inderpreet; Armstrong, April W.

doi:10.5070/d327854724

Cited by 8 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Visual aids, narrative stories, and clear statistical information on risks have all shown usefulness in mitigating risk-benefit alterations in ADHD and similar disorders (Aljubour et al, 2022;Bellani et al, 2011;Sleath et al, 2014). While we do not advocate graphic exaggeration, providers may find it helpful to describe and display a vivid case of acne scarring or lichen simplex chronicus, complications of acne, and eczema, respectively, to emphasize the importance of adhering to a patient-centered skin care regimen (UpToDate, n.d.; Yim et al, 2021).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Co-occurring ASD Mediates Impact of ADHD on Atopic Dermatitis and Acne: A Retrospective Cohort Study

Osman,

Gerard,

Hale

2023

J Atten Disord

View full text Add to dashboard Cite

Background: ADHD and ASD are associated with dermatologic manifestations, yet little research investigates co-occurring ADHD/ASD and common dermatologic conditions. Objective: To investigate associations between ADHD, ASD, acne vulgaris, and atopic dermatitis. Methods: Using de-identified patient records from the TriNetX database, we created four cohorts on ADHD diagnosis, ASD diagnosis, both, neither. Cohorts were separated into males and females. We balanced each cohort based on age, sex, race, and ethnicity to the baseline cohort with neither ASD or ADHD. Finally, we examined prevalence of acne and eczema. Results: The cohort sizes varied from 19,764 to 345,626. Compared to matched peers, males with ADHD or ADHD/ASD had increased prevalence of acne, and all neurodivergent males had increased prevalence of eczema. Females with ADHD had an increase in both. Females with ADHD/ASD had no significant differences, and females with ASD had a decreased risk of eczema. Limitations: Due to database limitations, we are unable to: analyze symptom severity, skincare routine, or treatment adherence. Conclusions: The decreased risk of eczema in females with ASD and lack of significant difference in incidence of acne or eczema in females with ADHD/ASD compared to matched peers suggests research into approaches to skincare in males versus females with ASD may provide clinically relevant insights.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Furthermore, current guidance suggests that patients with atopic dermatitis have a oncedaily bath with lukewarm water, limited to 5 to 10 minutes. Following these recommendations can help effectively manage atopic dermatitis symptoms (Frazier & Bhardwaj, 2020;Weidinger et al, 2018;Yim et al, 2021).…”

Section: Introductionmentioning

confidence: 99%

Co-occurring ASD Mediates Impact of ADHD on Atopic Dermatitis and Acne: A Retrospective Cohort Study

Osman,

Gerard,

Hale

2023

J Atten Disord

View full text Add to dashboard Cite

show abstract

The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness

Maynard

Armstrong

2023

Curr Derm Rep

View full text Add to dashboard Cite

Purpose of Review Immune-modulating treatments are used in dermatology for a variety of conditions. The authors aim to review the data regarding the safety of these treatments during the COVID-19 pandemic, namely the risk of infection with SARS-CoV-2 and the outcomes associated with COVID-19-related illness. Recent Findings Several large-scale studies found no increased risk of COVID-19 infection for patients on TNF-α inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, IL-23 inhibitors, dupilumab, and methotrexate. They also found that these patients did not have worse outcomes when infected with COVID-19. The data regarding JAK inhibitors, rituximab, prednisone, cyclosporine, mycophenolate mofetil, and azathioprine are more mixed. Summary Based on current research and guidelines from the American Academy of Dermatology and the National Psoriasis Foundation, dermatology patients on immune-modulating therapies can continue treatment during the COVID-19 pandemic when they are not infected with SARS-CoV-2. For patients who have COVID-19, guidelines encourage individualized assessment of the benefits and risks of continuing or temporarily withholding treatment.

show abstract

[Artículo traducido] Impacto de la pandemia de COVID-19 en los pacientes con dermatitis atópica

Pourani¹,

Ganji²,

Dashti³

et al. 2022

Actas Dermo-Sifiliográficas

View full text Add to dashboard Cite

La dermatitis atópica (DA) es una enfermedad cutánea crónica que puede desencadenarse debido a situaciones psicológicas y ciertos alérgenos. Los pacientes con DA pueden haber experimentado una exacerbación de la enfermedad debido al estilo de vida durante la pandemia de la COVID-19, incluyendo el confinamiento domiciliario y el incremento del estrés. Obtuvimos los datos electrónicos de 100 pacientes de DA ingresados en nuestro hospital de 2016 a 2019, y les llamamos con una línea telefónica específica. De los 100 pacientes, 43 eran varones y 57 mujeres (edad media ±DE: 45,85±16,90 ), de los cuales sesenta pacientes (37 mujeres y 23 varones, con edad media de 42,22±14,71) experimentaron el brote de la enfermedad durante la etapa de la COVID-19. La exacerbación de la DA guardó relación con la alteración de la dosis de tratamiento, un largo historial de dermatitis atópica, la duración del eccema, el auto-aislamiento, la frecuencia del lavado de manos, la desinfección de las manos, y la puntuación POEM (P<0,05). En lo referente a dicha puntuación, los 61 pacientes con DA de moderada a grave experimentaron mayor ansiedad que los 39 pacientes con DA de silente a leve (p=0,013). En este estudio muchos pacientes experimentaron exacerbación de la enfermedad y percibieron ansiedad leve durante la pandemia.

show abstract

Corrigendum: Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic

Cited by 8 publications

References 0 publications

Co-occurring ASD Mediates Impact of ADHD on Atopic Dermatitis and Acne: A Retrospective Cohort Study

Co-occurring ASD Mediates Impact of ADHD on Atopic Dermatitis and Acne: A Retrospective Cohort Study

The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness

[Artículo traducido] Impacto de la pandemia de COVID-19 en los pacientes con dermatitis atópica

Contact Info

Product

Resources

About